Melatonin is the hormone produced by the pineal gland known to regulate physiologic rhythms and to display immunomodulatory and neuroprotective properties. It has been reported that Alzheimer disease patients show impaired melatonin production and altered expression of the 2 G protein-coupled melatonin receptors (MTRs), MT 1 and MT 2 , but the underlying mechanisms are not known. Here we evaluated whether this dysfunction of the melatonergic system is directly caused by amyloid b peptides (Ab 1-40 and Ab 1-42 ). Ab treatment of rat pineal glands elicited an inflammatory response within the gland, evidenced by the up-regulation of 52 inflammatory genes, and decreased the production of melatonin up to 75% compared to vehicle-treated glands. Blocking NF-kB activity prevented this effect. Exposure of HEK293 cells stably expressing recombinant MT 1 or MT 2 receptors to Ab lead to a 40% reduction in [ 125
I]iodomelatonin binding to MT 1 . ERK1/2 activation triggered by MTRs, but not by the b 2 -adrenergic receptor, was markedly impaired by Ab in HEK293 transfected cells, as well as in primary rat endothelial cells expressing endogenous MTRs. Our data reveal the melatonergic system as a new target of Ab, opening new perspectives to Alzheimer disease diagnosis and therapeutic intervention.-Cecon, E., Chen, M., Marçola, M., Fernandes, P. A. C., Jockers, R., Markus, R. P. Amyloid b peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway. FASEB J. 29, 000-000 (2015). www.fasebj.org Key Words: Alzheimer disease • melatonin • melatonin receptors • nuclear factor kB • pineal gland ALZHEIMER DISEASE (AD) is the most common type of dementia worldwide, characterized by progressive cognitive impairment and memory loss. Senile plaques composed of aggregates of amyloid b (Ab) peptides are the main molecular hallmark of this age-related neurodegenerative disease. Ab is generated by cleavage of the transmembrane amyloid precursor protein and may vary from 39 to 42 amino acids in length, with Ab 1-40 and Ab being the 2 predominant forms (1) . A current consensus exists that soluble Ab oligomers, rather than Ab aggregates, are the most neurotoxic Ab species and might trigger the first molecular changes related to AD. Although the sequential cascade of events induced by these Ab oligomers is not fully understood, its neurotoxic effects most likely involve an early neuroinflammatory response. By acting through pattern-recognition receptors, such as TLR4, Ab activates microglia and astrocytes, inducing the production of inflammatory cytokines and reactive oxygen and nitrogen species (2) . Determining the inflammatory signature of AD holds great clinical value for the development of earlystage diagnostic methods.
So-called sundowning (worsening of symptoms when the sun goes down) and altered behavior are examples of circadian dysfunctions related to AD. Melatonin, the hormone of the pineal gland, is known to synchronize physiologic rhythms, and its production is markedly reduced in AD patients (3) (4) (5) . Apart from its chronobiotic effects, melatonin has been proposed to display additional neuroprotective and antiamyloidogenic properties. Melatonin was shown to inhibit Ab generation and aggregation and to attenuate t phosphorylation, which is another molecular hallmark of AD (6) . In addition, the known antioxidant and anti-inflammatory properties of melatonin are likely to contribute to maintain brain homeostasis (7) . Therefore, it is plausible to assume that impairment in pineal function may have important consequences regarding neurodegenerative processes.
We have shown that inflammatory mediators affect melatonin production through direct interaction with the pineal gland, which is part of the immune-pineal axis Abbreviations: [ 125 I]-Mel, 2-[ 125 I]iodomelatonin; AA-NAT, arylalkylamine N-acetyltransferase; AD, Alzheimer disease; Ab, amyloid b; BRET, bioluminescence resonance energy transfer; BRET 50 , acceptor/donor ratio concentration required to generate half-maximal bioluminescence resonance energy transfer signal; Ct, cycle threshold; DAMP, damage-associated (continued on next page) concept (8) . Specifically, pathogen-or danger-associated molecular patterns (PAMPs or DAMPs), such as LPS (Gram-negative bacterial lipopolysaccharide) and the cytokine TNF, activate TLR4 or TNF receptors, respectively, in pineal cells and trigger NF-kB signaling, which negatively affects melatonin production (9) (10) (11) (12) . The biosynthesis of melatonin involves acetylation of serotonin by the enzyme arylalkylamine N-acetyltransferase (AA-NAT), forming N-acetylserotonin (NAS), which is then methylated by the hydroxyindole O-methyltransferase (HIOMT) enzyme to form melatonin. The daily rhythm in melatonin production and secretion, with peak levels during nighttime, is driven by the hypothalamic suprachiasmatic nuclei, which control noradrenaline release from sympathetic terminals that innervate the gland. Noradrenaline signaling through b adrenoceptors induces the expression and/or activity of the AA-NAT enzyme (13) . The presence of NF-kB responsive elements in the promoter of Aanat gene has been previously demonstrated (14) , and it reinforces the idea that melatonin production is not exclusively under the photoperiodic control but also depends on the pathophysiological condition of the organism. On the basis of the known inflammatory properties of Ab, mediated by TLR4/NK-kB pathway, we hypothesized that the reduced levels of circulating melatonin in AD patients could be due to direct signaling of Ab peptides in the pineal gland. In addition to impaired melatonin production, AD patients also show reduced expression of melatonin receptors (MTRs) in the hippocampus and hypothalamus compared to age-matched control individuals (15, 16) . In mammals, most of the effects of melatonin are mediated by 2 specific MTRs, MT 1 and MT 2 , belonging to the GPCR superfamily (17) . MTRs are widely distributed in the nervous system and in peripheral tissues (18) and signal predominantly through G i and G q proteins (19) . In AD, the altered expression of MTRs suggests dampened MTR function. In fact, melatonin administration to AD patients has been demonstrated to be efficient in ameliorating sleep and circadian organization in clinical trials, underlining its therapeutic potential (20) . These beneficial effects were, however, not consistently observed in all trials, which might be explained by an impaired responsiveness of MTRs in some patients. Although several reports suggest a link between GPCRs and AD pathology, most focused on GPCR modulation of Ab generation, while little is known about Ab effects on GPCR function (21, 22) . To explore this possibility and evaluate whether the melatonergic system is directly affected by Ab peptides, we investigated the effects of Ab and Ab 1-42 peptides on melatonin synthesis in rat pineal glands and on the function of recombinant and endogenous MTRs in transfected cells or in rat endothelial cells, respectively.
MATERIAL AND METHODS

Animals
Adult male Wistar rats weighing 180 to 250 g were kept under a 12 hours light, 12 hours dark cycle (lights on at 6 AM) with water and food ad libitum. The animals were killed by decapitation, and the pineal glands were rapidly removed and placed in a 24-well culture plate. All experiments were carried out in compliance with the ethical standards of the National Council on Experimental Animal Control and were approved by the ethics committee of the Institute of Bioscience of the University of São Paulo (license 111/2010).
Drugs and reagents
1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP), 2-iodomelatonin (IMel), BGJb culture medium, bovine serum albumin, N,N9-methylenebisacrylamide, noradrenaline, poly(dI-dC), poly-L-lysine, pyrrolidinedithiocarbamate (PDTC), trypsin, and trypsin inhibitor were purchased from Sigma-Aldrich (St. Louis, MO, USA). ]-Easy Tides were purchased from PerkinElmer (Waltham, MA, USA), and acrylamide was purchased from Bio-Rad (Hercules, CA, USA). All solvents used were of synthesis grade.
Ab preparation
Lyophilized Ab 1-40 peptides were dissolved in DMSO and diluted in PBS to make a 100 mM stock solution (10% DMSO). Further dilutions were made in culture medium before use. Because Ab peptide is more prone to aggregate and form fibrils, we used a specific protocol to generate Ab 1-42 oligomers based on previous reports (23, 24) . Lyophilized Ab 1-42 peptides were first dissolved in HFIP and stocked in aliquots as a dry peptide film at 280°C after HFIP evaporation. Before use, the peptide film was reconstituted in DMSO, followed by addition of PBS to bring it to a 100 mM solution (10% DMSO). Further dilutions were made in culture medium. To generate the aggregated form of Ab , the solution was incubated at 37°C for 4 days before use. The oligomeric and aggregated conformations of Ab were checked by Western blot analysis (Supplemental Fig. S1 ) using the anti-amyloid antibody 6E10 (dilution 1:500; Covance, CA, USA).
Pineal gland culture
Rat pineal glands were cultivated in a 24-well plate (1 gland per well) in BGJb medium supplemented with 2 mM glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin, and maintained at 37°C (95% O 2 , 5% CO 2 , 48 to 72 hours). The medium was replaced every 24 hours. After 48 hours, the gland is totally denervated, allowing proper stimulation with noradrenaline (100 nM) for the last 5 hours of culture to induce melatonin production in vitro.
(continued from previous page) molecular pattern; HFIP, 1,1,1,3,3,3-hexafluoro-2-propanol; HIOMT, hydroxindole O-methyltransferase; HSP, heat shock protein; IKB, inhibitory kB; I-Mel, 2-iodomelatonin; IRF, IFN regulatory factor; IkB, NF-kB inhibitor; MTR, melatonin receptor; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NAS, N-acetylserotonin; P-AANAT, phosphorylated (activated) arylalkylamine N-acetyltransferase; PAMP, pathogenassociated molecular pattern; PDTC, pyrrolidinedithiocarbamate; p-ERK, phospho-ERK; Rluc, Renilla luciferase; TR, testicular receptor; YFP, yellow fluorescent protein
Pinealocytes culture
Pinealocytes were prepared from rat pineal glands as previously described (25) . Briefly, after removal from the animal, the pineal glands were submitted to partial digestion by trypsin (0.25%, 37°C, 15 minutes), followed by mechanical dispersion in the presence of trypsin inhibitor (0.3%) in PBS. After centrifugation (15 minutes, 1000 g), the cells were resuspended in complete DMEM supplemented with 10% v/v fetal bovine serum, plated on poly-L-lysine-coated 8-well chamber-slide plates (0.5 3 10 5 cells/ well) or 96-well plates, and maintained at 37°C, 5% CO 2 , overnight before experimentation.
HEK293 cell culture
HEK293 cells were grown in complete DMEM medium, supplemented with 10% (v/v) fetal bovine serum, 4.5 g/L glucose, 100 U/ml penicillin, and 0.1 mg/ml streptomycin and maintained at 37°C (95% O 2 , 5% CO 2 ). For radioligand binding and ERK assays, we used HEK293 cells transfected to stably express recombinant MT 1 or MT 2 receptors (26) . For bioluminescence resonance energy transfer (BRET) assays, HEK293 cells seeded in 6-well plates were transiently transfected with previously constructed plasmids coding MTRs conjugated to Renilla luciferase (Rluc) or conjugated to the yellow fluorescent protein (YFP) (26) . HEK293 cells were transfected with 10 ng of MT 1 -Rluc or 20 ng of MT 2 -Rluc and 10 to 2000 ng of MT 1 -YFP or MT 2 -YFP plasmids using the jetPEI reagent according to the supplier's instructions (Polyplus-transfection, New York, NY, USA).
Endothelial cell culture
Primary culture of rat endothelial cells was obtained from the cremaster muscle according to a previously described method (27, 28) . Briefly, the cremaster muscle was isolated, washed in PBS, and cut into pieces, which were then placed into a flask (75 cm 2 bottom surface) with DMEM, supplemented with 20% fetal bovine serum, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. The culture was maintained at 37°C (95% O 2 , 5% CO 2 ), and the tissues were removed from the flask after 48 hours. The cells were cultured until confluence, with the medium changed every 48 h, and subcultured in 24-well plates or 8-well chamberslide plates for experimental assays.
HPLC determination of indoleamines
Conditioned mediums from cultured pineal gland incubated with vehicles or with Ab peptides (Ab 1-40 0.03 mM or Ab 1-42 1 mM; 24 to 72 hours) followed by noradrenaline stimulation (100 nM, 5 hours) were analyzed for NAS and melatonin contents by HPLC as previously described (29) .
Viability assay
Dissociated pinealocytes seeded in 96-well plates were treated with Ab (1 mM, 30 minutes to 24 hours) and incubated in MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] tetrazolium-containing medium (0.5 mg/ml, 2 hours, 37°C). The formazan product formed by reduction of the MTT tetrazolium was solubilized with DMSO and the absorbance read spectrophotometrically at 540 nm.
Immunofluorescence assay
Dissociated pinealocytes were fixed with acetone:methanol solution (1:1, 15 minutes, 220°C) and permeabilized with Triton X-100 (0.1%). Slides were blocked and incubated (overnight, 4°C) with anti-phospho-AA-NAT (1:200 dilution; S-0814; SigmaAldrich), or tetramethylrhodamine-conjugated anti-iNOS (1:50 dilution; sc-651; Santa Cruz Biotechnology, Santa Cruz, CA, USA), or anti-p50 NF-kB subunit (1:100 dilution; sc-114x; Santa Cruz Biotechnology). FITC sheep anti-rabbit antibody (F7512; SigmaAldrich) was used to detect bound antibodies. The cell nuclei were stained with DAPI (1:3000 dilution; Santa Cruz Biotechnology). The slides were analyzed under confocal (Zeiss LSM 500) or fluorescence microscope (Axion; Carl Zeiss GmbH, Jena, Germany), and the fluorescence was quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). To analyze the viability of the pineal glands after 72 hours incubation with Ab 1-40 (0.03 mM) or Ab (1 mM), we monitored propidium iodide uptake (5 mg/ml; Invitrogen Molecular Probes, Eugene, OR, USA). After incubation with propidium iodide (2 hours, 30 minutes), glands were fixed in paraformaldehyde (4%), cryoprotected in 20% sucrose solution, and frozen in tissue freezing medium (Triangle Biomedical Science, Durham, NC, USA). Cryosections of 20 mm were mounted on gelatin-coated slides, the nuclei were stained with DAPI, and fluorescence was analyzed and quantified as previously described.
EMSA or gel shift
After Ab incubation, pineal glands were processed to nuclear protein extraction as previously described (29) , and 6 mg of protein was incubated with ;30,000 cpm of double-stranded oligonucleotide probes containing the NF-kB consensus sequence (59-AGTTGAGGGGACTTTCCCAGGC-39; Promega, Madison, WI, USA) radiolabeled with g-ATP-[ 32 P]. DNA-protein complexes were analyzed in nondenaturant 6% polyacrylamide gel, which was vacuum-dried and exposed (24-48 hours, 280°C) to XAR-5 Kodak film (Rochester, NY, USA). The autoradiograms were developed and quantified densitometrically using ImageJ software. Supershift assay was performed by incubating the protein extracts (45 minutes at room temperature) with 2 mg/ml of rabbit polyclonal affinity-purified antibodies against each NF-kB subunit: p50, RelA, p52, c-Rel, RelB, and Bcl3 (sc-114x, sc-109x, sc298x, sc-70x, sc-226x, and sc-185x, respectively; Santa Cruz Biotechnology) before EMSA analysis.
TNF detection by ELISA
TNF content was measured in the culture medium from pineal glands incubated with Ab 1-40 (0.1 mM, 2-6 hours) by commercial available rat TNF-a ELISA Ready-Set-Go kits (cat. 88-7340; eBioscience, San Diego, CA, USA), according to supplier's instructions (detection limit, 16 pg/ml).
Real-time RT-PCR and PCR array
Pineal glands and endothelial cells were processed to total RNA extraction using TRIzol reagent following the manufacturer's instructions. cDNA was generated from 1 mg of total RNA using SuperScript III reverse transcriptase. Pineal cDNA was used to quantify the relative mRNA expression of Aanat and Hiomt genes, normalized by the expression of Gapdh (housekeeping) gene, through real-time RT-PCR using SYBR Green PCR mix reagent. The sequences of forward (F) and reverse (R) primers used are as follow: 59-AGCGCGAAGCCTTTATCTCA-39 (Aanat, F); 59-AAG-TGCCGGATCTCATCCAA-39 (Aanat, R); 59-AGCGCCTGCTGTT-CATGAG-39 (Hiomt, F); 59-GGAAGCGTGAGAGGTCAAAGG-39 (Hiomt, R); 59-TTCTTGTGCAGTGCCAGCC-39 (Gapdh, F); 59-GTA-ACCAGGCGTCCGATACG-39 (Gapdh, R). The relative mRNA expression of 84 genes related to the Toll-like receptor signaling pathway was analyzed through PCR array (Cat. PARN-018; SABiosciences, Qiagen, Hilden, Germany). In this case, data were normalized by the expression of the hypoxanthine phosphoribosyltransferase 1 (Hprt1) gene, as its expression was the most constant from the 5 available housekeeping genes according to the cycle threshold (Ct) values from all samples. The expression of each gene was determined through the DDCt (1 mM, 15 minutes) inhibit noradrenaline-induced (100 nM, 30 minutes) AA-NAT phosphorylation accessed by immunofluorescence. Fluorescence quantification data are expressed as mean 6 SEM (a.u., arbitrary units); **P = 0.0001 compared to control group by Student's t test. F) Representative fluorescence microscopy image of P-AANAT (green) detection. Cell nuclei were stained with DAPI (blue). Scale bar, 10 mm. method and is represented as the fold change relative to the control group (vehicle). The expression of MTRs in endothelial cells was analyzed by RT-PCR using the following primers: 59-CCTCCTGTCTGCCCTTTAATC-39 (MT1, F); 59-CACCCAGAGAT-GAGAGTCTGC-39 (MT1, R); 59-AATTGCTGTGGTGTCCTTTTG-39 (MT2, F); 59-TCAGGCGTAGCTTTCTCTCAG-39 (MT2, R). The reaction was performed using Taq PCR mix (Qiagen), and the amplified products were analyzed on a 2% agarose gel.
Radioligand binding experiments
HEK293 cells stably expressing Flag-tagged MT 1 or Myc-tagged MT 2 receptors were collected after Ab treatment and immediately used for whole cell radioligand binding assays as previously described (30 . Assays were carried out in duplicate for 90-120 minutes at 37°C, followed by rapid filtration through GF/F glass fiber filters (Whatman, Clifton, NJ, USA). Filter-retained radioactivity was determined with a g-counter LB2111 (Berthold Technologies, Bad Wildbad, Germany).
Microplate BRET assay
HEK293 cells transiently transfected to express MT 1 or MT 2 receptors fused to Rluc or YFP molecules were plated in white 96-well microplates and treated with Ab peptides (1 mM, 24 hours). For BRET donor saturation curves, cells were transfected with fixed amount of Rluc (MT 1 -Rluc, 10 ng; MT 2 -Rluc, 30 ng) and increasing amounts of YFP (10 to 2000 ng). BRET assays were carried out as previously described (26, 31, 32) . Briefly, cells were incubated with Rluc substrate (coelenterazine h, 5 mM, 15 minutes, room temperature; Molecular Probes), and readings were performed with a lumino/fluorometer (Mithras; Berthold Technologies), which allows sequential integration of Rluc activity (measured at 475-495 nm) and YFP signal (517-543 nm). The BRET signal is defined as the excited YFP signal/Rluc signal ratio 3 1000, and data are expressed as the percentage of BRET max (maximum BRET signal) versus total YFP signal/Rluc signal ration. BRET 50 values (acceptor/donor ratio concentration required to generate half-maximal bioluminescence resonance energy transfer signal) were obtained from the saturation curves and refer to the concentration of the YFPconjugated partner able to generate 50% of the BRET max signal.
SDS-PAGE/immunoblot analysis
HEK293 cells or endothelial cells cultured in 24-well plates were starved and treated with vehicle or Ab peptides (overnight). The cells were then washed in PBS and scraped into lysis buffer composed of 62.5 mM Tris/HCl pH 6.8, 5% SDS, 10% glycerol, and 0.005% bromophenol blue. Denatured proteins were resolved in 12% SDS-PAGE gels (33) , transferred to nitrocellulose membranes, and immunoblotted with antibodies against ERK1/2 (1:3000 dilution; sc-154; Santa Cruz Biotechnology); phospho-ERK1/2 (p-ERK1/2; 1:1000 dilution; sc-7383; Santa Cruz Biotechnology), or monoclonal anti-flag antibody (SigmaAldrich). Immunoreactivity was revealed using secondary antibodies coupled to 680 or 800 nm fluorophores (LI-COR Biosciences, Lincoln, NE, USA), and readings were performed with the Odyssey LI-COR infrared fluorescent scanner (LI-COR Biosciences). A representative full image of p-ERK blotting showing the specificity of the antibody is displayed in Supplemental Fig. S2 . cAMP assay cAMP levels were determined in rat endothelial cells treated with the indicated concentrations of iodomelatonin for 30 minutes at room temperature in the absence or presence of 2 mM forskolin. Measurements were performed by homogeneous time-resolved fluorescence using the cAMP-femto-Tb kit (Cisbio, Codolet, France), according to the manufacturer's instructions.
Statistical analysis
Data are presented as means 6 SEM. Statistical analysis was performed by Student's t test when comparing only 2 groups, or ANOVA followed by Dunnett's multiple comparison test when comparing 3 or more groups. Values of P , 0.05 were considered statistically significant. 
RESULTS
Ab modulates melatonin production in cultured pineal glands
In order to evaluate whether Ab peptides have a direct effect on the function of the pineal gland, we incubated rat pineal glands with Ab 1-40 or Ab 1-42 before the stimulation of melatonin synthesis with noradrenaline (100 nM, 5 hours).
Glands incubated with Ab 1-40 (0.03 mM, 24-72 hours) or Ab (1 mM, 24-72 hours) showed impaired noradrenalineinduced NAS and melatonin production in a timedependent manner (Fig. 1A-C) . Interestingly, the inhibitory effect of Ab 1-40 on melatonin synthesis was greater (75% reduction) than that observed for Ab (40% reduction). Aanat mRNA level is decreased in pineal glands treated with Ab (Fig. 1D) , while Hiomt mRNA expression was not affected under these experimental Figure 3 . Ab 1-40 -induced activation of NF-kB pathway. A) Densitometry quantification of nuclear NF-kB content accessed by gelshift assay in rat pineal glands treated with vehicle (0 minutes, white bars) or with Ab 1-40 (0.03. 1 mM; 0-15 minutes; gray bars). Data are expressed as mean 6 SEM and represented as percentage of control (vehicle) group; n = 4-9 glands per point; *P , 0.05 by 2-way ANOVA followed by Dunnett's multiple comparison test. B) Representative gel of NF-kB/DNA complexes analysis by gelshift assay. (2) indicates negative control, in absence of nuclear protein extracts. C) Representative supershift assay performed to identify NF-kB subunits present in nuclear extracts obtained from pineal glands treated with vehicle (control) or Ab (1 mM, 5 minutes). Protein extracts were incubated with antibodies against NF-kB subunits (p50, RelA, p52, c-Rel, RelB, Bcl3), as indicated above each lane. (2) , no antibody; NC, negative control, in absence of nuclear protein extracts; C1, C2 = NF-kB/DNA complexes; NS, nonspecific complex. D) Immunofluorescence detection of p50 (green) in dispersed rat pinealocytes previously incubated with Ab 1-40 (0.03 mM; 5-30 minutes). Arrowheads indicate cytoplasmic localization of p50, while arrows point to nuclear localization of p50. Cell nuclei were stained with DAPI (blue). Scale bar, 10 mm. or Ab (Fig. 1E, F) . The viability of pineal cells after Ab treatment was verified by MTT viability assay in isolated pinealocytes (Ab 1-40 1 mM, 30 minutes to 24 hours; Supplemental Fig. S3A ), as well as by propidium iodide uptake in whole glands (Ab 1-40 0.03 mM, 72 hours; Ab 1-42 1 mM, 72 hours; Supplemental Fig. S3B ).
Ab activates the NF-kB pathway in the pineal gland
The NF-kB family comprises 6 different subunits (RelA, p50, c-Rel, p52, RelB, Bcl3) that act as homo-or heterodimers. In quiescent cells, inactive NF-kB dimers are located in the cytoplasm bound to inhibitory proteins (IkB). Upon stimuli, NF-kB dimers are released from IkB and translocate to the nucleus to regulate gene transcription (34) . Reconstitution of NF-kB dimers with neosynthetized IkB proteins terminates NF-kB activation (35) . To investigate whether the inhibitory effect of Ab on melatonin production is mediated by NF-kB pathway, we blocked NFkB activation with PDTC (25 mM) 24 hours before Ab 1-40 incubation (0.03 mM, 24 hours). As shown in Fig. 2 , PDTC treatment prevented the impairment in NAS and melatonin production, confirming the major role of the NF-kB pathway in modulating pineal activity in this condition. To characterize the activation of NF-kB upon Ab stimuli, we performed a gel-shift assay, which detects nuclear DNAbinding-competent NF-kB. Pineal glands incubated with 0.03 mM or 0.1 mM Ab 1-40 showed highest NF-kB nuclear content at 15 minutes after Ab 1-40 addition. Further increase of the Ab 1-40 concentration (1 mM) accelerated NFkB activation kinetics (peak at 5 minutes) while reaching similar maximal levels (Fig. 3A, B) . At 30 minutes, NF-kB activation returned to basal levels for all Ab 1-40 concentrations tested (data not shown), underlining the expected transient profile of its nuclear translocation.
Supershift assays were carried out in order to identify the NF-kB subunits that comprise the DNA-NF-kB complexes (C1 and C2) detected in control and in Ab 1-40 -treated pineal glands. The C1 complex was displaced by specific binding to p50, RelA, and, to a much lesser extent, c-Rel antibodies in both control and Ab-treated groups, while no consistent displacement was observed with p52, RelB, and Bcl3 antibodies (Fig. 3C) . The antibody against p50 displaced most of C1, indicating that p50 is the predominant subunit of this complex. Total shift of C1 was obtained in the presence of both p50 and RelA antibodies, suggesting 1 mM, 1 hour) . Data are expressed as mean 6 SEM (a.u., arbitrary units); P value obtained by Student's t test. C) Representative confocal microscopy images of iNOS detection (red) in bright field (left) and dark field (right). Scale bar, 10 nm. that this complex contains both p50-p50 homodimers and p50-RelA heterodimers. As the second complex (C2) was not shifted by any of the antibodies, we classified this complex as nonspecific. Collectively, nuclear translocation of p50, a NF-kB subunit known to have a repressive role on target gene expression, is in good agreement with the inhibitory action of Ab-induced NF-kB on melatonin synthesis.
The pineal gland is composed of 2 cell types: pinealocytes (endocrine cells producing melatonin) and glial cells, for example, astrocytes and microglia (10) . To show that Ab promotes nuclear NF-kB translocation in pinealocytes, we monitored p50 immunoreactivity in isolated pinealocytes. Treatment with Ab 1-40 (0.03 mM) induced nuclear translocation of p50 with peak levels at 15 minutes. At earlier (5 minutes) and later (30 minutes) time points, p50 was located predominantly in the cytoplasm (Fig. 3D) , which is in accordance with the kinetics observed in whole pineal glands. Taken together, these results indicate that Ab promotes translocation of p50 into the nucleus of pinealocytes to inhibit Aanat transcriptional activity and melatonin synthesis.
Ab induces an inflammatory response in the pineal gland
The neuroinflammatory response has been considered as one of the earliest pathologic events underlying AD development. Because the Ab-induced inflammatory response is known to depend on the TLR/NF-kB pathway, we next evaluated whether the same inflammatory outcome is observed in pineal glands treated with Ab. To extend the range of genes potentially regulated by Ab beyond the Aanat gene, we performed a PCR array containing 84 genes related to the TLR4/NF-kB pathway. Ab 1-40 treatment of pineal glands (0.1 mM, 2 hours) modulated the expression of 55 genes, including 52 up-regulated and 3 down-regulated genes (Fig. 4A) . All genes related to the TLR family (Tlr1 to Tlr7, Tlr9, and the Cd180 and Cd14 coreceptors), were up-regulated (Fig. 4B) . Similarly, TLR adaptors such as MYD88 and TRAM (Ticam2), and the MAP kinases belonging to the JNK family (Mapk8 or JNK1, and Mapk9 or JNK2) were also up-regulated (Fig. 4C, D) . Interestingly, Ab 1-40 -treated glands showed higher expression of the Hmgb1 (high-mobility group B1) gene, which codes for an intracellular protein that propagates inflammatory responses and participates in the switch from acute to chronic inflammation (36, 37) . Ab 1-40 also increased the expression of the transcription factors c-Jun and the IFN regulatory factors IRF-1 and IRF-3, which mediate IFN-g signaling (Fig. 4D) . Most of the genes related to the NF-kB pathway were up-regulated by Ab ( Fig. 4E) , including all the subunits (except RelA), the NF-kB related protein (Nfrkb), the kinases Irak1 and Irak2, and the inhibitory kB proteins, such as IKB-a (Nfkbia), IKB-b (Nfkbib), and IKB-like protein 1 (Nfkbil). It is noteworthy that NF-kB family genes are self-regulated, resulting in the classic oscillatory pattern of NF-kB nuclear translocation and activity through a negative feedback mechanism (38) . Ab 1-40 treatment of pineal glands also led to increased expression of some molecules classified as effectors (Fig.  4F) , including caspase 8, COX-2 (Ptgs2), and 2 nuclear receptors: the orphan nuclear receptor TR4 (Nr2c2 gene), also known as testicular receptor 4 (TR4), which may regulate mitochondrial function (39) , and the peroxisome proliferator-activated receptor a (Ppara), a transcription factor related to metabolic and inflammatory pathways, which can counteract NF-kB actions (40, 41) . Among the 84 analyzed genes, Ab 1-40 only down-regulated the expression of the heat shock proteins D1 (Hspd1) and A1a (Hspa1a), and ubiquitin-conjugating enzyme E2 variant 1 (Ube2v1) genes (Fig. 4C,F) . Ab 1-40 -treated glands also showed increased expression of the T-cell costimulatory molecules CD80 and CD86, and of the chemokines C-X-C motif chemokine 10 (Cxcl10) and C-C motif ligand 2 (Ccl2), most probably on the glial cells population. Notably, Ab 1-40 induced the expression of most of the cytokinerelated genes, including the cytokines lymphotoxin a (Lta), IL-1a, IL-2, IL-6, IL-10, IL-12a, IFN-g and granulocytecolony stimulating factor (Csf3), as well as the cytokine receptors TNF-R, IL-1R, and IL-6R (Fig. 4G) . Figure 4H displays TLR-triggered signaling cascades; highlighted in green are some of the molecules up-regulated by Ab in the pineal gland. Collectively, these data point toward an Ab-induced inflammatory response within the pineal gland, a condition that further aggravate the impairment of melatonin synthesis.
Production of the cytokine TNF is one of the earliest responses triggered by TLR/NF-kB signaling. Consistently, Ab 1-40 treatment of pineal glands (Ab 1-40 0.1 mM, 2-6 hours) increased the amount of TNF released in the culture medium, with a first peak after 2 hours and a second increase after 6 hours of incubation with Ab (Fig. 5A) . Further evidence of the inflammatory response induced by Ab in the pineal gland at the protein level was obtained through immunofluorescence analysis of iNOS. This analysis was performed in dispersed pinealocytes in order to provide further evidences for Ab-induced signaling through TLR/ NF-kB in pineal-specific cells. As expected, control cells showed weak basal levels of iNOS, while Ab 1-40 -treated cells (0.1 mM, 2 hours) exhibited a marked increase in iNOS expression (Fig. 5B, C) . Taken together, these data indicate that Ab induces an inflammatory response within the pineal gland that is mediated by the TLR/NF-kB pathway.
Ab effect on MTR dimerization
In order to explore additional effects of Ab on the melatonergic system, we determined the impact of Ab on melatonin MT 1 and MT 2 receptor function. Previous studies on the angiotensin II AT 2 receptor suggested that Ab can interfere with GPCR dimerization and consequently modify receptor function (42, 43) . To verify whether Ab has a similar effect on the formation or conformation of MTR homo-and heterodimers, we applied the previously developed BRET donor saturation assay (26, 30) . The Rluc energy donor and the YFP energy acceptor were fused to the carboxyl terminus of MT 1 and MT 2 receptors. Coexpression of a fixed amount of MT 1 -Rluc or MT 2 -Rluc and increasing amounts of MT 1 -YFP or MT 2 -YFP in HEK293 cells resulted in a hyperbolic saturation curve with increasing YFP/Rluc ratios for all receptor combinations, reflecting the expected specific interaction between BRET donor and acceptor pairs (Fig. 6) . Preincubation of cells with Ab or Ab (1 mM, 24 hours) did not alter the donor saturation curves between any of the tested BRET pairs ( Fig. 6A-C ; Table 1 ), indicating that the peptides do not affect the propensity of MTRs to form di(oligo)mers and do not induce conformational changes of these complexes that are detectable by BRET assay.
Ab interferes with melatonin binding and signaling through MTRs
We then determined the impact of Ab treatment (1 mM, 24 hours) on the ligand binding properties of MT 1 Fig. 7A; Table 2 ). This effect appears to be specific for the Ab 1-42 peptide, as no effect was detected with the Ab 1-40 peptide. The effect of Ab was dose dependent, with a pIC 50 value negative log of half maximal inhibitory concentration of 7.2 (6 0.37) (Fig. 7B) Fig. 7C; Table 2 ). Moreover, the effect of Ab on MT 1 receptors depends on the conformational state of the peptide, as the aggregated form of Ab 1-42 was without effect (Fig. 7D) . Western blot analysis revealed that the Ab peptide treatment did not modify the amount of expressed MT 1 receptor protein (Fig. 7E) ) altered the number of MT 2 receptor binding sites; nor did they alter the affinity of both MTR subtypes for melatonin ( Fig. 7F; Table 2 ).
To study the effect of Ab and Ab 1-42 on MTR signaling, we monitored activation of the ERK1/2 signaling pathway. Incubation of HEK293 cells stably expressing MT 1 or MT 2 receptors with I-Mel (100 nM) induced ERK1/2 phosphorylation with peak levels between 2 to 5 minutes. Preincubation of cells with Ab or Ab (1 mM, overnight) markedly reduced or completely abolished this effect, respectively (Fig. 8A-D) . Importantly, ERK phosphorylation upon activation of the b 2 -adrenergic receptor by isoproterenol (100 nM, 0-20 min) was not affected by Ab pretreatment (Fig. 8E, F) , implying that Ab specifically targets MTRs-dependent ERK1/2 signaling. In order to confirm the inhibitory effect of Ab on melatonin-promoted ERK activation in cells expressing endogenous MTRs, we recapitulated the ERK activation experiments in primary cultures of rat endothelial cells. These cells represent a relevant model to evaluated Ab effects on MTRs because melatonin is an important modulator of endothelial cell function (44) . In addition, endothelial dysfunction is believed to contribute to AD onset, according to the vascular hypothesis of AD development (45) . Endogenous expression of MT 1 and MT 2 receptors in primary cultures of rat endothelial cells was confirmed by RT-PCR (Supplemental Fig. S4A ). Functional assays provided further evidence of the presence of MTRs on these cells. Melatonin treatment inhibited forskolin-induced cAMP production (Supplemental Fig. S4B ) and induced ERK1/2 activation, which is blocked in the presence of the selective MTRs antagonist luzindole (Supplemental Fig.  S4C) . Similarly to what was observed in HEK293 cells, pretreatment of endothelial cells with either Ab or Ab 1-42 peptides (1 mM, overnight) completely blunted I-Mel-induced ERK1/2 phosphorylation (Fig. 9) . Taken together, these results suggest that Ab peptides severely interfere with MTR-promoted ERK1/2 signaling.
DISCUSSION
Despite of the progress in AD research during the last 2 decades, deciphering Ab-specific targets and mechanisms of action involved in AD etiology is still challenging. The present study found the melatonergic system to be a new target of Ab peptides. In the pineal gland, Ab activates the NF-kB pathway, leading to an inflammatory response within the gland and impaired melatonin production. Ab also affects melatonin signaling through MT 1 and MT 2 membrane receptors. HEK293 cells stably expressing MT 1 or MT 2 receptors, as well as endothelial cells expressing endogenous MTRs, showed impaired activation of the ERK pathway induced by melatonin when cultivated in the presence of Ab peptides. In addition, Ab 1-42 significantly reduces the number of MT 1 melatonin binding sites.
The effects of Ab on pineal gland function, such as induction of inflammatory response and inhibition of melatonin synthesis, are in accordance with the recently described immune-pineal axis concept, which discloses the bidirectional interaction between the immune and the melatonergic systems (8) . According to this scenario, the NF-kB transcription factor has emerged as a key player, underlying the modulatory effects of inflammatory agents on melatonin synthesis (46) . Ab acts as a DAMP molecule that activates the NF-kB pathway, thus inhibiting melatonin production and releasing inflammatory mediators. NF-kBdependent inflammatory response in glial cells by Ab is well documented (47) . However, to our knowledge, this is the first report showing an extensive characterization of an inflammatory response within the pineal gland. Abinduced expression of several chemokines and cytokines suggests a microglia-mediated response, while the detection of NF-kB activation and iNOS expression in isolated pinealocytes indicate the participation of pineal endocrine cells in this inflammatory response. Inasmuch as the proinflammatory cytokine TNF also exerts negative modulation on melatonin production through the NF-kB pathway (10, 11), we can conclude that cross-talk between pineal cells further aggravates Ab-induced impairment in melatonin production. Finally, Ab induced the transcription of a number of TLRs and cytokine receptors, which suggests that the pineal gland becomes more susceptible to inflammatory mediators, PAMPs, or DAMPs. Thus, a synergic effect of these molecules on the inhibition of melatonin synthesis appears plausible and may underlie the persistent disruption of pineal function observed in AD.
It is interesting to note that Ab 1-40 negatively regulated only 3 genes, namely Hspd1, Hspa1a, and Ube2v1. The first 2 genes code for the heat shock proteins HSP60 and HSP70, respectively. Our results are in line with previous reports showing reduced expression of both proteins in the hippocampus of AD animal model (48) . HSPs play an important role in refolding or degrading denatured proteins, and overexpression of HSP70 was shown to rescue cognitive deficits in AD mice (49) . HSP60 might also mediate Ab-induced mitochondrial dysfunction, as this protein is required to proper mitochondrial protein import and the HSP60/Ab complex is increased in mitochondria isolated from AD brains (50) . Similarly, the UEV-1 enzyme (Ube2v1 gene) is also related to protein aggregation, as it participates in the polyubiquitination process of target proteins that drives proteasome degradation. The inhibitory action of Ab on genes involved in protein quality control may further aggravate Ab detrimental effects inasmuch as this condition favors Ab self-assembly.
The disclosure of the above-mentioned changes in pineal function triggered by Ab provides a mechanistic basis to explain impaired melatonin production in AD patients who are already in the first stages of disease (4) . Because the pineal gland is a circumventricular organ (51) , soluble DAMPs such as Ab can easily reach the gland, and thus pineal dysfunction might represent one of the first events triggered by increased levels of Ab. The modulatory effects on pineal activity were detected in the picomolar range, which is consistent to Ab oligomer concentrations in cerebrospinal fluid (52). Finally, persistent disruption of melatonin production during AD progression can be a consequence of continuous secretion of Ab peptides together with increased production of inflammatory mediators.
On the basis of the overall beneficial effects of melatonin and on its low toxicity, several studies have proposed and evaluated the therapeutic value of melatonin in neurodegenerative conditions. The absence of significant effects with melatonin treatment in some trials (20, 53) , in association with previous reports on deficient MTR expression (15, 16) , prompted us to investigate putative detrimental effects of Ab on the function of MTRs. Indeed, the data obtained in the present study clearly show that melatonin signaling is severely affected by Ab peptides, disclosing MTRs to be novel Ab targets as well. Previous studies have demonstrated that MTRs exist as homo-and heterodimers, which exhibit specific pharmacological and signaling profiles (54) . Contrary to a previous report on angiotensin type 2 receptor (42, 43) , no evidence of Ab-driven changes in dimer/oligomer formation between MTRs was detected. The most notable effects of Ab have been observed on MT 1 -and MT 2 -mediated signaling through the ERK pathway, which was remarkably impaired in cells expressing either recombinant or endogenous MTRs. The lack of Ab effect on ERK activation triggered by b 2 -adrenergic receptors points to the specificity of Ab action on MTRs and excludes a direct interference of Ab on the proper function of the ERK1/2 pathway. The precise mechanisms underlying this specificity for MTRs are not known but might rely on different sensitivities of different GPCRs to Ab effects or on the different localization of GPCRs in membrane microenvironments that are more susceptible to Ab-induced damage. Other envisioned hypotheses include a direct effect of Ab on the receptor or on its G protein coupling, as well as an effect on signaling components that are used by the MTRs but not the b 2 -adrenergic receptor.
Intriguingly, Ab 1-42 significantly reduced [ 125 I]-Mel binding sites in HEK293 cells expressing MT 1 receptors without affecting the expression levels of MT 1 . To our knowledge, Ab-dependent changes in agonist binding and signaling through GPCRs have been previously only reported for M 1 muscarinic acetylcholine receptors, for which uncoupling of the receptor from the G protein in the presence of Ab has been suggested (55) . A similar mechanism is plausible to underlie the observed effects of Ab on MT 1 because [ 125 I]-Mel is an agonist and its highaffinity binding depends on the presence of the G protein ternary complex (agonist-receptor-G protein). Alternatively, Ab-induced MTRs dysfunction could be due to an increase in receptor internalization rate, impairment in the transport of the receptor to the membrane, or conformational change that makes the melatonin binding site unavailable. Therefore, further studies are needed to reveal the exact mechanisms underlying Ab modulation of MTRs function. Here we provide strong evidence that Ab severely interferes with melatonin signaling through MT 1 and MT 2 receptors, which might represent new therapeutic targets in AD, inasmuch as rescuing their function could improve the effectiveness of melatonin administration to AD patients. The functional relevance of Ab-induced abolishment of melatonin signaling through the ERK1/2 pathway can be inferred from some reports showing that the antiapoptotic effect of melatonin is dependent on MTR-triggered ERK1/2 signaling (56, 57).
The consequences of damped melatonin synthesis and signaling are still poorly understood. Melatonin is a highly versatile molecule, displaying distinct roles ranging from the synchronization of physiologic rhythms to modulation of immune responses, cell redox balance, and amyloidogenic processes (7) . Several studies have documented the effect of melatonin on cognitive function as well. Melatonin was shown to modulate cholinergic transmission by upregulating physiologic responses mediated by a7 nicotinic acetylcholine receptors (58) (59) (60) , a mechanism that might underlie melatonin's beneficial effects regarding reduced cholinergic neurodegeneration, rescued hippocampal long-term potentiation and improved learning and memory reported in a mouse model of Down syndrome (61) . Accordingly, blockage of melatonin production, either by targeting the HIOMT enzyme or by exposing the animals to light/light condition, significantly worsens the animal's performance in learning and memory behavioral tests (62, 63) . The role of MTRs on cognitive function, however, is not clear. MT 2 receptor-deficient mice (64) show impaired hippocampal long-term potentiation and performance in learning/memory behavioral test, while MT 1 / MT 2 double-knockout mice show no clear differences in the same behavioral test and an increase in long-term potentiation (65) . Neuroprotective actions of melatonin against cytotoxic compounds such as Ab and LPS have also been shown (66) (67) (68) . In fact, the ability of cerebellar granule cells to produce melatonin confers resistance against LPS toxicity, while antagonizing MTRs with luzindole significantly increases cell death (68) .
In summary, the present study shows that the melatonergic system is markedly impaired when exposed to Ab 1 mM, overnight) . B) Quantification of p-ERK1/2 and ERK1/2 content. Data are expressed as mean 6 SEM of 5 independent experiments and are represented as percentage of basal level from each group; *P , 0.05, **P , 0.005 relative to control by 2-way ANOVA followed by Dunnett's multiple comparison test.
peptides, revealing that both components-the pineal gland and MTR function-are directly targeted by Ab. To our knowledge, this represents the first evidence of a direct effect of Ab peptides on the melatonergic system, which might be at the origin of dampened melatonin rhythm and MTRs function observed in AD patients. Changes in the melatonergic system could therefore be added to the list of potential biomarkers with predictive value of early AD stages, a task that remains to be accomplished. Moreover, early impairment of the melatonergic system might contribute to Ab cytotoxicity and thus AD progression. Melatonin administration to AD patients has been suggested on the basis of the multifaceted properties of this molecule (7, 69) . Thus, restoring melatonin circulatory levels and rescuing receptors function may be of therapeutic value, especially melatonin administration to late-stage AD patients. Therefore, the present study provides new molecular mechanisms underlying Ab detrimental effects and also provides new perspectives on the therapeutic and/or predictive value of melatonin in AD. Figure S1 -Representative eletrophoretic analysis of amyloid beta solutions. Amyloid beta peptides were dissolved as described (see Methods) and separated on a 16% / 6M Urea TrisTricine polyacrylamide gel, followed by immunobloting using the 6E10 antibody. 
